Denis Chem Lab Ltd.
Snapshot View

View in App

Prices View details

56.05 -2.90 ▼-4.9%

05 August 2021, 04:00:00 P.M.
Volume: 15,915

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.denischemlab.com
Financial Indicators
Market Cap 78.20 Cr.
Earnings per share (EPS) 1.63 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 34.54 Trailing Twelve Months Ending 2021-03
Industry PE 32.75 Trailing Twelve Months Ending 2021-03
Book Value / Share 44.32 Trailing Twelve Months Ending 2021-03
Price to Book Value 1.27 Calculated using Price: 56.35
Dividend Yield 1.33 Period Ending 2020-03
No. of Shares Subscribed 1.39 Cr. 13,876,668 Shares
FaceValue 10
Company Profile
No Company Profile found.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-4.92%
1 Week
-0.18%
1 Month
+2.28%
3 Month
+6.86%
6 Month
+40.12%
1 Year
+26.24%
2 Year
+27.39%
5 Year
-37.35%

Ratios View Details

9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 12.76 22.77 14.13 0.62 -30.41 5.86 5.37 11.94 7.29
Return on Capital Employed (%) 18.76 21.77 15.80 10.93 5.30 12.19 9.37 11.90 11.34
Return on Assets (%) 3.14 5.54 2.87 0.12 -5.36 1.38 2.20 6.15 4.15

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 7 8 9 17 16 30 50 56 59
Non Curr. Liab. 3 5 18 25 22 20 11 6 4
Curr. Liab. 17 21 25 39 46 44 40 43 34
Minority Int.
Equity & Liab. 26 35 52 81 85 94 101 106 97
Non Curr. Assets 10 11 19 44 51 46 48 51 47
Curr. Assets 16 24 33 37 34 48 53 54 50
Misc. Exp. not W/O
Total Assets 26 35 52 81 85 94 101 106 97

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 42 56 67 77 100 113 107 124 136
Other Income 0 0 0 0 0 1 1 2 0
Total Income 42 56 68 77 100 114 108 126 136
Total Expenditure -37 -50 -61 -68 -91 -99 -95 -110 -121
PBIDT 4 6 6 10 9 15 13 16 15
Interest -2 -2 -3 -5 -7 -6 -5 -3 -3
Depreciation -1 -1 -1 -4 -6 -7 -6 -6 -7
Taxation 0 -1 -1 0 -1 -1 0 0 -2
Exceptional Items
PAT 1 2 1 0 -4 1 2 6 4

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 2 -1 -2 14 21 7 11 8 13
Cash Fr. Inv. 0 -1 -9 -28 -13 -1 -16 -2 -2
Cash Fr. Finan. -2 4 12 13 -7 0 1 -5 -14
Net Change -1 1 0 -1 1 5 -4 1 -3
Cash & Cash Eqvt 0 2 3 2 3 6 2 3 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 38.98 38.98 38.98 38.98 38.98 38.98 38.98 38.98 38.98
Public 61.02 61.02 61.02 61.02 61.02 61.02 61.02 61.02 61.02
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Thu, 05 Aug 2021
Announcement under Regulation 30 (LODR)-Newspaper Publication
We are enclosing herewith clippings of Newspapers Advertisement addressed to the Shareholders published on 5th August 2021 for your information and records.

This is in due compliance of the relevant Regulations of the SEBI (LODR) Regulations 2015.
Mon, 02 Aug 2021
Board Meeting Intimation for Taking On Record Unaudited Financial Results For The Quarter Ended On 30Th June 2021<BR>
Denis Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended on 30th June 2021.

Please note that as intimated to the Exchange vide Letter dated 28th June 2021 the Trading Window of the Company shall continue to remain closed for designated persons till 48 hours after the declaration of Financial Results for the quarter ended on 30th June 2021 in terms of Companys Code of Conduct for prevention of Insider Trading and SEBI (Prohibition of Insider Trading) Regulations 2015.
Mon, 26 Jul 2021
Corporate Action Fixes Book Closure For 40Th AGM.
The Board of Directors in their meeting held today have fixed Book Closure for the 40th AGM of the Company.

Technical Scans View Details

Thu, 05 Aug 2021
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Closing Below Previous Low Closing Below Previous Low
CCI Bearish CCI Bearish
William %R Trending Down William %R Trending Down

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 188,551.74 785.85 +0.0%
Divi's Laboratories Ltd. 130,702.13 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. 79,575.04 4,783.30 +0.2%
Cipla Ltd. 76,243.85 945.20 +0.6%
Cadila Healthcare Ltd. 59,868.47 584.80 -0.5%
Piramal Enterprises Ltd. 59,065.41 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. 58,599.44 4,075.50 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 31.41 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 65.87 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.80 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 31.70 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 28.06 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 44.33 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 389.73 4,075.50 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 3.94 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 14.06 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.45 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 4.17 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 4.61 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1.73 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.75 4,075.50 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 0.10 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,075.50 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 14.13 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,075.50 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 32.07 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 17.85 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 10.03 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,075.50 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 19,159.59 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,075.50 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 2,401.30 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,075.50 +0.2%